Caisse De Depot Et Placement Du Quebec Biomarin Pharmaceutical Inc Transaction History

Caisse De Depot Et Placement Du Quebec

$50.2 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $2.73 Million - $3.38 Million	-36,653 Reduced 93.19%	2,677 $220,000
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $2.36 Million - $2.78 Million	-28,118 Reduced 41.69%	39,330 $3.44 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $1.73 Million - $2.24 Million	22,735 Added 50.85%	67,448 $6.5 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $1.09 Million - $1.21 Million	-12,800 Reduced 22.26%	44,713 $3.96 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $444,668 - $514,539	5,130 Added 9.79%	57,513 $4.99 Million
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $2.43 Million - $3.25 Million	-27,700 Reduced 34.59%	52,383 $5.09 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $3.26 Million - $4.38 Million	40,300 Added 101.3%	80,083 $8.29 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.3 Million - $1.53 Million	15,787 Added 65.79%	39,783 $3.37 Million
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $553,112 - $672,045	-7,738 Reduced 24.38%	23,996 $1.99 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $2.11 Million - $2.63 Million	28,400 Added 851.83%	31,734 $2.45 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $221,973 - $283,099	-3,095 Reduced 48.14%	3,334 $295,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $104,678 - $119,658	1,400 Added 27.84%	6,429 $497,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $379,739 - $426,408	5,029 New	5,029 $420,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $203,308 - $252,560	-2,800 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $114,992 - $209,648	-1,600 Reduced 36.36%	2,800 $213,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $75,572 - $118,009	-950 Reduced 17.76%	4,400 $543,000
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $103,486 - $140,432	1,450 Added 37.18%	5,350 $452,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $385,620 - $518,220	-6,000 Reduced 60.61%	3,900 $330,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $20,220 - $25,533	300 Added 3.13%	9,900 $667,000
Q2 2019 Aug 09, 2019	SELL	$80.35 - $93.9 $24,105 - $28,170	-300 Reduced 3.03%	9,600 $822,000
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $202,080 - $236,688	-2,400 Reduced 19.51%	9,900 $879,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $24,042 - $31,820	-300 Reduced 2.38%	12,300 $1.05 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $892,240 - $1 Million	9,500 Added 306.45%	12,600 $1.22 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $76,010 - $99,030	-1,000 Reduced 24.39%	3,100 $292,000
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $100,971 - $120,419	1,300 Added 46.43%	4,100 $332,000
Q4 2017 Feb 13, 2018	SELL	$80.76 - $95.13 $104,988 - $123,669	-1,300 Reduced 31.71%	2,800 $250,000
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $330,460 - $389,295	4,100	4,100 $383,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.

Account